HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential agglutination by soybean agglutinin of human leukemia and neuroblastoma cell lines: potential application to autologous bone marrow transplantation.

Abstract
Normal human bone marrow cells were mixed with radioactively labeled tumor cells from different leukemia and neuroblastoma cell lines, and the cell mixtures were separated by differential agglutination with soybean agglutinin. It is shown that the cell fraction unagglutinated by soybean agglutinin, which was previously found to be capable of reconstituting the hematopoietic system of lethally irradiated recipients, can be purged of tumor cells with varying efficiency depending on the tumor cell expression of soybean agglutinin receptors as detected by flow cytofluorimetry with fluoresceinated soybean agglutinin.
AuthorsY Reisner
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 80 Issue 21 Pg. 6657-61 (Nov 1983) ISSN: 0027-8424 [Print] United States
PMID6356131 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Lectins
  • Plant Lectins
  • Soybean Proteins
  • soybean lectin
Topics
  • Animals
  • Antigens, Neoplasm (analysis)
  • Bone Marrow Cells
  • Bone Marrow Transplantation
  • Cell Line
  • Cross Reactions
  • Humans
  • Immunologic Techniques
  • Immunotherapy
  • Lectins
  • Leukemia (therapy)
  • Leukemia, Experimental (immunology)
  • Neuroblastoma (immunology)
  • Plant Lectins
  • Soybean Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: